Search research articles
Contact Us
Filters
Showing results (761-770 of 801) with videos related to
Page
of 81
Sort By:
ESMO Open
|
May 4, 2024
Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
BMC Cancer
|
July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
G Sommerhäuser, A Kurreck, S Stintzing, et al.
Obstetrics and Gynecology
|
May 28, 2020
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection
Maria Andrikopoulou, Nigel Madden, Timothy Wen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2025
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO
M M Germani, V Heinemann, D Rossini, et al.
Cell Host & Microbe
|
April 25, 2023
The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection
Arne Bublitz, Madita Brauer, Stefanie Wagner, et al.
ESMO Open
|
August 15, 2022
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
ESMO Open
|
October 26, 2024
Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 27, 2025
Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis
Jennifer J Shin, Meghan Wilson, Margo McKenna, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 29, 2025
Executive Summary of the Clinical Practice Guideline on the Surgical Management of Chronic Rhinosinusitis
Jennifer J Shin, Meghan Wilson, Margo McKenna, et al.
Science Advances
|
October 23, 2024
Enhancing economic multifunctionality without compromising multidiversity and ecosystem multifunctionality via forest enrichment
Larissa Regina Topanotti, Jasper M Fuchs, Matthias Albert, et al.
Page
of 81
Search research articles
Search
Showing results (761-770 of 801) with videos related to
Sort By:
Page
of 81
ESMO Open
|
May 4, 2024
Corrigendum to "Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
BMC Cancer
|
July 27, 2022
Study protocol of the FIRE-8 (AIO-KRK/YMO-0519) trial: a prospective, randomized, open-label, multicenter phase II trial investigating the efficacy of trifluridine/tipiracil plus panitumumab versus trifluridine/tipiracil plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer
G Sommerhäuser, A Kurreck, S Stintzing, et al.
Obstetrics and Gynecology
|
May 28, 2020
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection
Maria Andrikopoulou, Nigel Madden, Timothy Wen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 21, 2025
Risk of disease progression in the first-line therapy of metastatic colorectal cancer to guide disease re-assessments - analysis of eleven trials by AIO and GONO
M M Germani, V Heinemann, D Rossini, et al.
Cell Host & Microbe
|
April 25, 2023
The natural product chlorotonil A preserves colonization resistance and prevents relapsing Clostridioides difficile infection
Arne Bublitz, Madita Brauer, Stefanie Wagner, et al.
ESMO Open
|
August 15, 2022
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
ESMO Open
|
October 26, 2024
Corrigendum to "Prognostic and predictive value of CA 19-9 inlocally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113)": [ESMO Open 7 (2024) 100552]
I Hartlapp, D Valta-Seufzer, J T Siveke, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 27, 2025
Clinical Practice Guideline: Surgical Management of Chronic Rhinosinusitis
Jennifer J Shin, Meghan Wilson, Margo McKenna, et al.
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery
|
May 29, 2025
Executive Summary of the Clinical Practice Guideline on the Surgical Management of Chronic Rhinosinusitis
Jennifer J Shin, Meghan Wilson, Margo McKenna, et al.
Science Advances
|
October 23, 2024
Enhancing economic multifunctionality without compromising multidiversity and ecosystem multifunctionality via forest enrichment
Larissa Regina Topanotti, Jasper M Fuchs, Matthias Albert, et al.
Page
of 81